NHPC LtdNSE: NHPC
Open the NHPC Ltd page
Follow NHPC LtdFree account. Get a note when NHPC Ltd files.
Q2 FY27 results analysis · November 04, 2026

NHPC Ltd Q2 FY27 Results Analysis: PAT Jumps 52%, EBITDA Margin Expands 395 bps

+51.7%PAT year on year, Rs. 1,549.09 Cr
Cofacto ResearchPublished November 04, 20264 min readPositive read
Quick summary

NHPC Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 4,482.55 Cr (+33.20% YoY) and PAT growth of +51.66% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateNovember 04, 2026
Revenue (Q2)Rs. 4,482.55 Cr (+33.20% YoY)
PAT (Q2)Rs. 1,549.09 Cr (+51.66% YoY)
EBITDA margin64.18% (+395 bps YoY)
EPS (Q2)Rs. 1.54 (+50.00% YoY)

Quarter Snapshot

Q2 FY27 consolidated revenue grew 33.20% YoY to Rs.4,482.55 crore with PAT to owners up 51.66% to Rs.1,549.09 crore and EBITDA margin up 395 bps YoY to 64.18%, driven by newly commissioned Subansiri Lower and Parbati-II capacity (Rs.1,231.64 crore provisional sales). Key watch items are the doubling of finance costs, a 62.90% receivables build, and both CERC tariff orders still pending, which keep the new-station sales provisional with notified-tariff upside ahead. Subansiri Unit 5 commissioning on October 23, 2026 keeps the FY27 capacity ramp on track against the Rs.15,000 crore capex target.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
Generation/PAF vs deficit monsoon ("−12.6%, lowest since 2015")Behind on water volumesNot disclosed in filing — not observableNot observable
Revenue "behind on water, cushioned by the new-capacity ramp"Revenue growth capacity-ledReported +33.20% YoY but ex-provisional +3.28%Played out
CERC orders pending; 80%-AFC booking persistedSwing factor unresolvedBoth orders still pending; Rs.1,231.64 provisional sales bookedPlayed out
Finance cost stays elevated YoYHeadwind+100.28% YoY to Rs.556.17Played out
Working-capital pressure persistsHeadwindReceivables +62.90% vs Mar-26Played out
Teesta-V resumption reverses ~Rs.400 Cr annual under-recovery from Q2PositiveNo quantum disclosed in filingNot observable
One-time items: Rs.392.31 arbitral award (tariff-recoverable); Teesta-IV uncertainty—Award not addressed in filing; Teesta-IV provision Rs.231.30 confirmed from filing note and normalized — provision); award openPlayed out

Read our full results preview.

Management Guidance vs Delivery

What management saidWhereWhat happenedVerdict
Subansiri balance 4 units by Dec 2026 (2,994 MW FY27 hydro)Q1 FY27 presentation / earnings-call guidanceUnit 5 COD Oct 23, 2026; 1,250 MW of 2,000 MW (filing note 10)On Track
FY27 consolidated capex Rs.15,000 CrFY27 capex guidance given on the Q1 FY27 earnings callH1 consol capex Rs.5,685.06 = 37.90% of targetStretch
Hydro regulated equity Rs.30,672–30,723 Cr by end-FY27Q1 FY27 investor presentationReg-deferral debit Rs.8,817.92 at Sep-26; end-FY27 level not derivable from a Q2 filingToo Early
Parbati-II final CERC order by June 30, 2026February 2026 earnings-call guidanceNote 6(ii): still "pending final approval of the CERC"Missed
Subansiri interim tariff ~2 months from March 2026 petitionQ4 FY26/Q1 FY27 call guidanceNote 6(i): still "pending approval of the CERC"Missed
Pakal Dul (Dec 2026), Kiru (Dec 2026), Rangit-IV (Oct/Nov 2026)Q1 FY27 presentationNo commissioning status in the Q2 filingToo Early
New units and Teesta-V resumption "expected to progressively contribute to top-line growth"Q1 FY27 results filingRevenue +33.20% YoY, with Rs.1,231.64 provisional sales from new capacityConfirmed
80% conservative AFC booking is "just timing difference" pending CERCQ3 FY26/Q1 FY27 callsBoth tariff orders still pending at Q2; provisional booking continues — mechanism intact; reversal timing unprovenToo Early
CERC unlikely to disallow beyond-control costs ("very less chances of any sort of disallowance")Prior earnings callsTeesta-IV Rs.231.30 provision shows implementation uncertainty is real on one project; no CERC disallowance evidence yetToo Early

Key Numbers, Quarter by Quarter

MetricFY26Q1 FY27Q2 FY27
Consolidated generation (MU)29,6199,486not disclosed in filing
PAF %74.7580.79not disclosed in filing

Key Investment Insights

Key Positives

  • Consolidated revenue grew 33.20% YoY to Rs.4,482.55 crore; standalone revenue grew 50.97% YoY
  • Consolidated PAT attributable to owners grew 51.66% YoY to Rs.1,549.09 crore; normalized PAT growth of 67.91% after adding back the Rs.231.30 crore Teesta-IV provision
  • Consolidated EBITDA margin of 64.18%, up 395 bps YoY and 238 bps QoQ
  • Subansiri Lower and Parbati-II provisional sales of Rs.1,231.64 crore in Q2 vs Rs.217.69 crore a year ago; Subansiri Unit 5 (250 MW) commissioned October 23, 2026, taking the project to 1,250 MW of 2,000 MW
  • H1 consolidated CFO of Rs.3,179.16 crore was 1.12x PAT; operating cash flow grew from Rs.1,583.21 crore to Rs.3,179.16 crore YoY
  • Effective tax rate fell to 28.25% from 34.08% YoY
  • H1 capex of Rs.5,685.06 crore is 37.90% of the FY27 Rs.15,000 crore target, with H2 requirement of Rs.9,314.94 crore only 8.38% above FY26 H2 actual

Risk Factors

  • Ex-provisional sales, established fleet revenue grew only 3.28% YoY, indicating growth is commissioning-led rather than like-for-like volume-driven
  • Consolidated finance costs doubled YoY (+100.28%) to Rs.556.17 crore as commissioning-driven interest capitalization ends
  • Trade receivables rose 62.90% vs March-26 to Rs.4,283.37 crore, consistent with discom-dues pressure
  • Rs.231.30 crore provision against Teesta-IV HE Project survey & investigation CWIP due to implementation uncertainties
  • Both CERC tariff orders (Parbati-II final, Subansiri interim) remain pending past guided timelines, leaving Rs.1,231.64 crore of Q2 sales provisional
  • Tax expense recognized on expected Section 200(5) transition is subject to review during forthcoming quarters, an unquantified forward tax risk

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.